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ascular endothelial growth factor (VEGF-A) is a major
regulator of blood vessel formation and function. It
controls several processes in endothelial cells, such
as proliferation, survival, and migration, but it is not known
how these are coordinately regulated to result in more
complex morphogenetic events, such as tubular sprouting,
fusion, and network formation. We show here that VEGF-A
controls angiogenic sprouting in the early postnatal retina
by guiding ﬁlopodial extension from specialized endothelial
cells situated at the tips of the vascular sprouts. The tip cells
V
 
respond to VEGF-A only by guided migration; the proliferative
response to VEGF-A occurs in the sprout stalks. These two
cellular responses are both mediated by agonistic activity
of VEGF-A on VEGF receptor 2. Whereas tip cell migration
depends on a gradient of VEGF-A, proliferation is regulated
by its concentration. Thus, vessel patterning during retinal
angiogenesis depends on the balance between two different
qualities of the extracellular VEGF-A distribution, which
regulate distinct cellular responses in deﬁned populations
of endothelial cells.
 
Introduction
 
The development of branched tubular organs like the vascular
system, lung, kidney, and many glandular tissues poses several
fundamental biological questions. What determines the cellular
architecture of tubes and how do new branches arise? What
controls the size of a new branch and the direction of its out-
growth? How do branches fuse to form a continuous network?
The most pervasive vertebrate tubular organ, the vasculature,
is first assembled from scattered precursor cells that shape
blood islands, which fuse to create the first primitive plexus
of vessels (Risau and Flamme, 1995). Subsequently, enlarge-
ment and remodeling of the plexus, involving sprouting,
splitting, and regression of branches, shape hierarchical vascular
patterns that allow directional blood flow. These patterns
become precisely adapted to organ anatomy and physiology,
hence they differ extensively between organs.
Principally, at least two different mechanisms may lead to
organ-specific vascular patterns. First, the formation of a
primary vascular network may be a random process followed
by specific branch regression. This “vascular pruning” repre-
sents a major mechanism of vascular remodeling and is likely
regulated at the level of endothelial cell survival, which depends
on vascular endothelial growth factor (VEGF-A)* and un-
identified signals from surrounding vascular smooth muscle
cells or pericytes (Benjamin et al., 1999). Second, angiogenic
sprouting and fusion may be a guided process, leading to
specific primary vascular patterns. Such angiogenic guidance
is mainly inferred by the seemingly nonrandom angiogenic
sprouting in the developing central nervous system (CNS),
for example, in the mammalian retina, where a vascular
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plexus initially forms superimposed on a preexisting astrocyte
plexus (Stone and Dreher, 1987; Fruttiger et al., 1996).
Precision guidance of specialized cells is involved in the
formation of other pervasive organ systems. Axonal guidance
by attractive and repulsive forces is well established, and also
the formation of the insect tracheal system, which is both
structurally and functionally analogous to the vertebrate vas-
culature, relies on guidance of cells and subcellular processes
along predefined tracks (for review see Zelzer and Shilo,
2000). Certain molecules with a role in axon and/or tracheal
guidance have also been implicated in vascular morphogene-
sis (for review see Shima and Mailhos, 2000). For angiogen-
esis, however, the functions of these and other angiogenic
modulators remain ill defined.
The concept of precision guidance requires a sensor that
relays external signals into specific cell behavior. In axonal
guidance, this is provided by a specialized tip structure, the
growth cone. Also, the guidance of 
 
Drosophila
 
 tracheal
branches depends on specialized sensor cells situated at the
sprouting tips. These tip cells are unique in morphology and
gene expression and appear to respond to guidance cues con-
ferring positional information (Samakovlis et al., 1996).
Both the growth cone and the tracheal tip cells use dynamic
filopodia to sense guidance cues in their surroundings and to
migrate (Kater and Rehder, 1995; Ribeiro et al., 2002).
There is evidence from several studies that endothelial
sprouts can also extend multiple filopodia at their distal tips
(Bär and Wolff, 1972; Marin-Padilla, 1985 and earlier litera-
ture cited therein), indicating that growing vascular sprouts
are endowed with specialized tip structures with potential
functions in guidance and migration. These descriptions
have received surprisingly little attention, and with few re-
cent exceptions (Dorrell et al., 2002; Ruhrberg et al., 2002)
they go unnoticed in today’s concepts of vascular develop-
ment. Importantly, the numerous pro- and antiangiogenic
factors discovered during the past 15 yr have not been stud-
ied in relation to endothelial tip cells and their filopodia, and
in particular, the possibility that endothelial tip cells may re-
spond specifically to such factors has not been explored.
By analyzing mice lacking heparin-binding VEGF-A iso-
forms, we have recently provided evidence that the spatial
distribution of secreted VEGF-A is critical for the balance
between capillary branching and growth in vessel size (Ruhr-
berg et al., 2002). Here, we have used several genetic and
pharmacological gain and loss of function approaches to
show that different modes of VEGF-A distribution in the
extracellular space independently guide tip cell migration
and control proliferation in stalk cells. Collectively, our data
explain how the pattern of cellular expression and extracellu-
lar distribution of a single growth factor shapes vascular pat-
terns during angiogenic sprouting by regulating different
events in defined subpopulations of endothelial cells.
 
Results
 
We focused our studies of developmental angiogenesis on the
early postnatal mouse retina, which develops a stereotypical
vascular pattern in a well-defined sequence of events (Fig. 1).
Simultaneous vascular sprouting at the periphery and remod-
eling at the center (observable, for example, at postnatal day
[P]5), allows the study of different aspects of vessel forma-
tion, maturation, and specialization in a single preparation.
Retinas are ideal structures to visualize using whole-mount
immunostaining and in-situ hybridization techniques, cou-
pled with high resolution three-dimensional imaging by con-
focal laser scanning microscopy. We studied retinas from var-
ious mice between birth (P0) and P14. During this time,
spreading of the inner vascular plexus proceeds from the op-
tic disc to the peripheral margin. From approximately P6,
vascular branches also extend from the inner plexus into the
retina to form the outer plexuses (Fig. 1, P8, arrows).
 
Characterization of the endothelial tip cell
 
High resolution imaging of isolectin B4–stained retinas re-
vealed that the endothelial cells at the tips of vascular sprouts
extended long filopodia (Fig. 2, a–d and f). In the retina,
this was most evident at the edge of the expanding inner vas-
cular plexus (Fig. 2, a and b), at sites of sprouting into and
within the deeper retinal layers (Fig. 2 c), and at prospective
fusion sites in the central, remodeling zone (Fig. 2 d, ar-
rows). Endothelial filopodia were uniform in thickness
(
 
 
 
100 nm) but of variable length, with the longest extend-
ing 
 
 
 
100 
 
 
 
m. Staining of nuclei in combination with
isolectin B4, vascular endothelial (VE) cadherin, and fi-
bronectin (Fig. 2, a and e) revealed that the sprouting tip
consisted of a single, highly polarized endothelial cell, here-
after referred to as the tip cell. The endothelial identity of
this cell was further confirmed by staining for platelet–
endothelial cell adhesion molecule (PECAM)-1, endomucin
(unpublished data), and VEGF receptor (VEGFR)2 (see
Figure 1. Schematic presentation of retina development as a 
model system for investigation of angiogenic sprouting in the CNS. 
Corresponding top view micrographs of whole mount isolectin-
labeled specimen are shown to the right. The top view displays the 
primary plexus in the fiber layer of the retina. Sprouting occurs 
toward the periphery in the primary plexus (P1 and P5, arrows) and 
subsequently into deeper layers (P8, arrows), where again branching 
and fusion leads to plexus formation.T
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Fig. 5, d–f). Therefore, we consider the tip cell the leader in
the phalanx of endothelial cells constituting a vascular
sprout. Accordingly, trailing cells are referred to as stalk
cells. Double staining for endothelial markers and nuclei re-
vealed that the extension of long filopodia is largely re-
stricted to the tip cells. Staining of the actin cytoskeleton by
phalloidin conjugates highlighted the tip cells and in partic-
ular their leading edge and filopodia (Fig. 2 f). Tip cells were
also distinguished from stalk cells by their strong expression
of PDGF-B mRNA (Fig. 2 g) and VEGFR2 mRNA and
protein (see Fig. 5, d–f), implying that tip cells have a gene
expression profile that is distinct from the stalk cells. PDGF-
B has been shown previously to play an essential role in the
recruitment of pericytes to new vessels (Lindahl et al., 1997).
The VEGFR2 expression in tip cells is further discussed be-
low. Vascular perfusion with labeled dextran demonstrated
that the vascular lumen extends up to but not into the tip
cells (Fig. 2 h). Together, these characteristics suggest that
the tip cells are distinct and functionally specialized mi-
crovascular endothelial cells. Their morphology and localiza-
tion in the sprout is schematically illustrated in Fig. 2 i. Tip
cells were not unique to the retina but were present in other
parts of the developing mouse CNS harboring active angio-
genesis (unpublished data).
To determine whether vascular sprouting in the CNS in-
volved expansion of the endothelial population from the tip
or the stalk, we performed double labeling of BrdU or the
proliferation marker Ki-67, and isolectin B4. We did not
observe proliferating tip cells in either 10 P5–P7 retinas la-
beled with Ki-67 or an additional 10 labeled with BrdU
(Fig. 2, j–l). In contrast, proliferation was abundant in stalk
cells and in the immature capillary plexus but occurred also
in veins and to a lesser extent in arteries (Fig. 2 l; unpub-
lished data). This suggests that tip cells are nonproliferative;
proliferation in the spreading plexus occurs in the sprout
stalks and further back in the remodeling plexus.
The abundance of filopodia on tip cells is indicative of an
active migratory phenotype. To study more directly the dy-
namics of tip cell behavior in real time, we used an organ
culture model of vessel sprouting adapted from the rat aortic
ring model (Nicosia and Ottinetti, 1990) in which all exter-
nal stimuli such as TPA, VEGF, or bFGF were omitted.
These modifications resulted in a system that is entirely self
driven, characterized by rapid growth of sprouts, which
form lumens and are enveloped by mural cells (unpublished
data). The tips of the sprouts were composed of highly mi-
gratory cells with numerous filopodia- and lamellipodia-like
processes (Fig. 3 a and see Fig. 6 i). Time-lapse recordings
revealed that protrusion and retraction of lamellipodia from
these tip cells was a highly dynamic process with single en-
dothelial cells being retained at the tip of the sprout (Fig. 3
a). Endothelial proliferation was conspicuous in stalk cells
(Fig. 3 c); however, we did not observe tip cell mitosis using
Ki-67 or phospho-histone staining. Thus, with respect to
the functional polarization in the sprout, angiogenesis in the
aortic ring assay mimics retinal angiogenesis.
 
Tip cell filopodia extend on VEGF-producing astrocytes
 
The inner retinal vascular plexus develops in close associa-
tion with a preexisting layer of astrocytes (Stone and Dreher,
1987; Fruttiger, 2002). We confirmed that the retinal vascu-
lar plexus initially forms super imposed on the astrocyte net-
work that remodels after contact with the vasculature (Fig.
4 a). These two plexuses subsequently dissociate in the remod-
eling zone, indicating a transient importance of their close
interaction in the peripheral sprouting region. All tip cells
were closely attached to astrocytes and stretched most of
their filopodia along the astrocyte cell bodies and processes
(Fig. 4 b, filled arrowheads). Filopodia without apparent as-
trocyte contact were consistently shorter and undulating
(Fig. 4 b, open arrowheads).
These observations suggest that an astrocyte scaffold
guides the extension of tip cell filopodia. Previous studies
have implied that astrocytes are dominant in retinal vessel
pattern formation (Fruttiger et al., 1996). To analyze if
changes in the architecture of the astrocyte plexus were
dominant also with regard to the guidance of tip cell filopo-
dia, we studied transgenic mice in which the growth factor
PDGF-A was expressed under the astrocyte-specific glial
fibrillary acidic protein (GFAP) promoter (Fruttiger et al.,
2000). Since astrocytes strongly express the PDGF-A recep-
tor (PDGFR
 
 
 
) (Fruttiger, 2002), autocrine mitogenic stim-
ulation results in super-numerous astrocytes intertwining
into a dense network of radially oriented bundles (Fig. 4 h).
The endothelial tip cells and their filopodia oriented along
these abnormal astrocyte bundles (Fig. 4, g and h), leading
to the formation of a super imposed multilayered vascular
network (Fig. 4 f). PDGF-A knockout mice developed a
sparser network of astrocytes and vessels, however, with re-
tained association between tip cell filopodia and the astro-
cyte network (Fig. 4, i–k). Together, the effects of astrocyte
hyper- or hypoplasia on retinal vascular patterning suggest
that astrocytes provide the principal cues for guidance of en-
dothelial tip cells and their filopodia.
Previous studies have shown that astrocytes express
VEGF-A in CNS angiogenesis during developmental and
pathological processes (Pierce et al., 1995; Stone et al.,
1995; Provis et al., 1997). To map VEGF-A expression to
specific cell types, we performed VEGF-A in situ hybridiza-
tion in combination with isolectin/GFAP double staining.
VEGF-A mRNA expression only occurred in GFAP-posi-
tive retinal astrocytes (Fig. 5, a–c), with the strongest sig-
nals located in astrocytes at the leading edge and immedi-
ately ahead of the plexus. VEGF-A mRNA was also
detected in astrocytes further back in the plexus surround-
ing veins and capillaries but not surrounding arteries (un-
published data).
 
VEGF-A stimulates tip cell filopodia
 
Since tip cell filopodia extended along VEGF-A mRNA-
positive astrocytes, we asked whether ectopic VEGF-A
could induce filopodial extension from endothelial cells.
Support for this idea came from examination of the hyaloid
vasculature in transgenic mice overexpressing VEGF from
the lens-specific 
 
 
 
A-crystallin promoter. (The generation
and basic characterization of these mice will be reported
elsewhere [unpublished data].) Hyaloid arteries extend
from the optic disc and ramify around the lens supporting
its early development, and ultimately these regress postna-
tally. The hyaloid arteries are normally straight vessels withT
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Figure 2.
 
Characterization of the endothelial tip cell. 
 
Isolectin staining is shown in green and nuclei staining is shown in blue. e, endothelium; 
m, macrophages/microglia. (a) High magnification confocal micrograph showing typical filopodia extension at the leading edge of the primary 
retinal plexus. Note the single endothelial nucleus. (b) Double labeling for isolectin and macrophage marker F4/80 distinguishes between 
endothelium (e, only green) and macrophages (m, green and red). Arrows point to sprouting tips. (c) Filopodia at sprouting tips in the deeper 
retinal plexus, and (d) at remodeling sites (arrows) in the primary plexus. (e) High magnification of a sprouting tip triple labeled for VE-cadherin 
(cell borders and junctions), fibronectin (astrocytes and vessel basement membrane), and nuclei. Note focal filopodia extension at the tip 
(arrow), whereas following cells extend no filopodia (arrowheads). (f) Filopodia are highly enriched in actin filaments (red and green, arrows T
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Figure 3. Tip cell migration and stalk cell proliferation in the aortic ring sprouting model. (a) Selected sequence from a time-lapse movie 
focusing on a single sprout prelabeled for PECAM-1 (red). Note lamellipodia protrusions and continued migration of the leading cell (arrows). 
(b) Representative image of a single sprout labeled for PECAM-1 (red) and mitosis (phospho-histone, green) and nuclei (Blue). Note that 
proliferation is confined to the stalk; tip cells do not proliferate (see star and panel c). Total sprout length from the ring margin to the tip of 
each sprout was measured in a single ring quadrant from each of the three time points (days 5, 7, and 9). The distance from the ring to mitotic 
endothelial cells along these same sprouts was also measured. The histograms represent the mean of the total length of PECAM-positive sprouts 
over the 3 d versus the mean length distance to endothelial cell mitosis.
 
and blow up inset), whereas endothelial cells without filopodia show little actin (green, arrowheads). (g) PDGFB in situ hybridization reveals 
tip cell–specific gene expression (arrows). (h) Dextran perfusion (false colored in red) revealing endothelial lumina. Note lumen-free tip cell 
to the left. (i) Graphic illustration of tip cell and stalk cell terminology. (j) Overview micrograph visualizing endothelial proliferation in the 
plexus (arrows) but not in the tip region (box, magnified in k). Note lack of Ki67 labeling or Brdu labeling in tip cells (stars), whereas stalk 
cells and plexus cells near the tip label weakly (arrows). (l) Distribution of proliferating endothelial cells given as percent of the total. 10 retinas 
labeled for Ki67 were analyzed. Note lack of tip cell proliferation (star). Bars, 20 
 
 
 
m.
 
smooth abluminal surfaces and few branch and fusion
points; however, those in 
 
 
 
A-crystallin–VEGF164 trans-
genics were densely covered with abluminal filopodia.
These hyaloid vessels were also aberrantly fused into chaotic
vascular networks (Fig. 6, a–c).These observations indicate
that VEGF overexpression is sufficient to induce continu-
ing filopodial extension, vascular sprouting, and hyperfu-
sion in vessels in which these processes normally have
ceased. However, these studies do not discriminate between
the possibilities that filopodial extension is directly and dy-
namically regulated by VEGF or whether it is inherent to a
tip cell phenotype induced by VEGF. To address these al-T
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Figure 4.
 
Astrocytes guide endothelial tip cell filopodia.
 
 (a) Over view micrograph, displaying overlap of vascular and astrocytic network. 
Note that the leading edge of the vascular plexus (arrows) is clearly visible in the astrocytic pattern (arrowhead). (b) High magnification 
illustrating alignment of tip cell filopodia with astrocytic processes (filled arrowheads). Note undulating appearance of filopodia that lack T
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ternatives, we acutely deprived the growing retinal vascula-
ture of VEGF-A by injecting a soluble VEGFR1 extracellu-
lar domain–Fc fusion protein (soluble Flt) into the eyes of
P5 mice. Soluble Flt has a high affinity for VEGF-A and
acts as a potent extracellular VEGF-A trap. 6 h after injec-
tion, most tip cell filopodia were completely retracted in the
sprouting region (Fig. 6, d–g). To assess the dynamics of
VEGF-A–regulated tip cell process extensions and migra-
tion, we employed the aortic ring assay. Filopodial retrac-
tion was widespread after addition of soluble Flt but not af-
ter treatment with other Fc fusion proteins (Fig. 6, h–k).
Time-lapse videomicroscopy also showed that the protru-
sive activity of tip cell lamellipodia was impaired in con-
junction with a block in tip cell migration and sprout elon-
gation (Fig. S1, available at http://www.jcb.org/cgi/content/
full/jcb.200302047/DC1).
 
VEGF stimulates tip cell filopodia via VEGFR2
 
VEGF-A binds to and signals through two receptors,
VEGFR1 (Flt-1) and -2 (Flk-1) (Ferrara, 1999), which are
coexpressed in angiogenic endothelium. In the retina,
VEGFR2 in situ hybridization highlighted tip cells, but
there was also significant signal in the stalk (Fig. 5 d). How-
ever, VEGFR1 mRNA expression was similar in both tip
and stalk cells (Fruttiger, 2002). VEGFR2 protein staining
was prominent on tip cell filopodia (Fig. 5, e and f).
The intensity of VEGFR2 immunostaining on the
filopodia suggested that this receptor is implicated in
VEGF-mediated filopodia protrusion. To test this hypothe-
sis, neutralizing VEGFR2-specific antibodies were injected
into the eyes of P5 mice, and the retinas were removed for
examination 6 h later. The tip cell filopodia were retracted,
and plexus spreading was inhibited (Fig. 6, n and o), sug-
 
astrocytic contact (open arrowheads). (c–k) Illustration of the dominant effect of astrocytes on the retinal vascular plexus. Vessel density is 
regulated by astrocyte density (c). Wild-type overview displaying a single layer of vessels in alignment with the astrocytic network (d and e). 
(f) Supernumerous astrocytes in GFAP-PDGFA transgenics lead to multilayered blood vessels (see also z scan inset). Tip cells truthfully follow 
the aberrantly dense astrocytic cords (g and h). (i–k) PDGFA deficiency leads to a sparse vascular network as a result of a sparse astrocytic 
network. m, macrophages; e, endothelial cells. Bars, 20 
 
 
 
m.
Figure 5. Illustration of tip cell guidance toward VEGF sources and of VEGFR expression on endothelial filopodia. (a–c) Confocal laser 
scanning micrographs of VEGF-A in situ hybridization (black signal) combined with double labeling for isolectin and GFAP. (a) Overview 
illustrating strong VEGF-A expression ahead of the vascular plexus and very low behind the leading edge. (b) Higher magnification showing 
astrocytic VEGF-A expression (black and red overlap) and strong down-regulation in astrocytes covered by the primary plexus. (c) Tip cell 
filopodia orientate toward and along VEGF-A–expressing astrocytes. (d) VEGFR2 in situ hybridization identifies strongest expression in the tip 
cells (arrows). (e and f) VEGFR2 is prominent on tip cell filopodia (arrowheads). (e) Rat mAb labeling using tyramide enhancer kit on cryosection, 
and (f) goat polyclonal antibody on whole mount labeling together with isolectin.T
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gesting that VEGFR2-mediated signaling is necessary for
tip cell filopodial extension. A neutralizing VEGFR1 anti-
body had no effect on tip cell morphology or their filopodia
(Fig. 6, l and m). We conclude that the extension and
maintenance of tip cell filopodia depends on VEGF-A sig-
naling via VEGFR2.
Figure 6. Illustration of filopodia induction in hyaloid vessels of VEGF164tg. (a) Wild-type littermate showing normal smooth surface of 
the hyaloid vessels (arrows) lying on the inner surface of the retina. Filopodia are only present in the intraretinal vascular plexus (asterisks). 
(b and c) Hyaloid vessels in VEGF164tg are studded with filopodia (arrows and inset). Bundles of filopodia are involved in sprouting and 
fusion (arrowhead), leading to an aberrant hyperfused vascular structure. Bars, 20  m. VEGF is necessary for filopodia extension: (d–g) acute 
sequestering of VEGF by intraocular injection of soluble Flt-1–IgG chimeric protein leads to filopodia retraction already after 6 h (earliest time 
point investigated). (h–k) VEGF sequestering inhibits tip cell filopodia in the aortic ring assay. (l–o) Acute neutralization of VEGFR2 (n and o) 
but not VEGFR1 (l and m) leads to retraction of tip cell filopodia.T
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Spatially restricted VEGF guides tip cell filopodia
 
We next asked if VEGF is directly involved in the guidance of
filopodia along the astrocyte scaffold. Considering their
length and display of VEGFR2 protein, the tip cell filopodia
may be capable of sensing VEGF-A at considerable distance
from the cell soma. However, it is also possible that VEGF-A
stimulates random protrusion of filopodia and that other fac-
tors (e.g., extracellular matrix) subsequently guide the filopo-
dia. Direct guidance by VEGF-A would require the existence
of precisely shaped extracellular gradients or deposits of
VEGF-A protein, which could be sensed by the filopodia. We
showed recently that the heparin-binding isoforms VEGF164
and 188 are required for the establishment of steep extracellu-
lar VEGF gradients in the mouse embryonic hindbrain
(Ruhrberg et al., 2002). Therefore, we asked if heparin-bind-
ing VEGF-A isoforms had a similar role in the retina. RT-PCR
indicated that VEGF164 is the dominant isoform expressed
in the developing retina followed by 120, 144, and 188 (Fig.
7 a). Immunolabeling showed that extracellular VEGF-A is
distributed mainly along the astrocyte tracks in developing
wild-type retinas (Fig. 7 b). In contrast, mouse mutants ex-
pressing only VEGF120 (120/120 mice) lacked a distinctive
astrocytic association of extracellular VEGF; instead VEGF120
is distributed more diffusely in the retina (Fig. 7 c). This find-
ing is consistent with the shallow gradient of VEGF protein
around the hindbrain midline demonstrated previously in
120/120 mice (Ruhrberg et al., 2002).
Normally, the tip cell filopodia extend directionally in a
narrow plane defined by the astrocytic network (Fig. 7, d
and h). Such filopodia also exist in VEGF120/120 mice, but
they were fewer in number and shorter than in the wild-type
retinas (Fig. 7, e, i, and l). In addition, VEGF120/120 mu-
tant tip cells extended filopodia also in several directions,
i.e., upward (toward the inner limiting membrane (ILM),
and backward (peripheral to central) (Fig. 8, a and b). Exces-
sive filopodia extending from stalk cells were also seen.
Filopodia that were not oriented centroperipherally and par-
allel to the astrocytic network were generally undulating and
lacked clear spatial orientation (Fig. 8 b). In conclusion, the
wide extracellular distribution of VEGF-A in 120/120 reti-
nas correlated with loss of tip cell filopodial polarity.
In addition to a change in distribution of extracellular
VEGF-A, the remaining VEGF-A protein in VEGF120/
120 mice lacks VEGF164 and 188–specific COOH-termi-
nal sequences. This may affect signaling in ways that are
critical for guidance. For example, VEGF164 (but not 120)
binds to the axonal guidance receptor neuropilin-1, which
enhances signaling via VEGFR2 in endothelial cells (Soker
et al., 1998). In an attempt to distinguish between the pos-
sibilities of isoform-specific signaling and extracellular
VEGF gradients as alternative mechanisms of filopodial
guidance, we compared the VEGF120/120 retinas with
retinas from transgenic mice that overexpress specific VEGF
isoforms and from mice injected intraocularly with VEGF164.
When overexpressed from the lens-specific 
 
 
 
A-crystallin
promoter, each of the VEGF120, 164, or 188 isoforms led
to abnormal filopodial guidance, including ectopic filopo-
dia and a shortening of the remaining astrocyte-associated
filopodia, similar to the situation in VEGF120/120 mice
(Fig. 7, f and j; unpublished data). Direct injection of
VEGF164 had a similar effect (Fig. 7, g, k, and l). The most
severe misguidance, which also resulted in entire tip cells
extending across the ILM and into the vitreous, was seen in
 
 
 
A-crystallin–VEGF120 mice (Fig. 8 c), probably reflect-
ing chronic exposure to high concentrations of VEGF (un-
published data).
In summary, aberrantly oriented filopodia were seen in all
situations in which disruption of a normal extracellular
VEGF gradient occurred. However, aberrant filopodia ori-
entation was not associated with the presence or absence of
specific VEGF isoforms. Thus, a properly shaped extracellu-
lar pattern of VEGF-A distribution, rather than specific
VEGF-A isoforms or concentrations, is necessary for the
correct guidance of tip cell filopodia.
 
Tip cell migration depends on the distribution, whereas 
stalk cell proliferation depends on the concentration of 
VEGFR2 agonistic activity
 
In addition to the sensor role, filopodia are known to exert a
motor function. Abnormal filopodial guidance would then
correlate with altered or decreased tip cell migration. As a
measure of directed tip cell migration, we assessed the pe-
ripheral spreading of the inner retinal plexus in the various
situations of altered VEGF distribution. We observed slower
spreading in 120/120 and 
 
 
 
A-crystallin–VEGF mice and in
response to direct intraocular injections of VEGF-A (unpub-
lished data; see also Fig. 9, j and k).
The observation that a disturbed VEGF-A gradient inhib-
its both filopodial extension and peripheral endothelial
spreading in the retina suggests that directed tip cell migra-
tion depends on the ability of the tip cell to distinguish re-
ceptor signaling arising at the tips of filopodia from signals
arising at the cell soma. To address the VEGFR dependence
of this ability, we used a panel of VEGFR-specific ligands.
Placenta growth factor (PlGF) and VEGF-B are selective
ligands for VEGFR1 (Eriksson and Alitalo, 1999). No en-
dogenous mammalian VEGF is selective for VEGFR2; how-
ever, the orf virus–encoded VEGF-E protein shows selective
high affinity binding to VEGFR2 (Ogawa et al., 1998; Wise
et al., 1999). We produced recombinant VEGF-E protein
and characterized its receptor-binding properties. This pro-
tein bound and activated the VEGFR2 protein selectively
(Fig. 9 a). VEGF-E injection into the eye led to dramatic in-
hibition of peripheral plexus spreading (Fig. 9, j and k) and
to associated shortening of tip cell filopodia (Fig. 9, d and
h). It also led to protrusion of short, ectopic filopodia from
stalk cells (unpublished data). In contrast, injections of PlGF
had no significant effect on spreading or filopodial exten-
sion, but it apparently had other biological effects, resulting
in massive influx of macrophages (Fig. 9, c and g). A third
VEGFR, VEGFR3, is mainly expressed in lymphatic endo-
thelium in late embryogenesis and postnatal life but also
plays a role in early blood vessel development (Dumont et
al., 1998). After intraocular injections of the VEGFR3-selec-
tive ligand VEGF-C156S (Joukov et al., 1998), there was a
lack of detectable effects on tip cell filopodial extensions in
the developing retina (Fig. 9, e and i). Based on the selective
and specific retinal responses to VEGF-E, we conclude that
retinal tip cell migration depends on an intact gradient of
VEGFR2 agonistic activity.T
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Figure 7.
 
VEGF gradients shaped by heparin-binding isoforms are necessary for directed tip cell filopodia extension.
 
 (a) RT-PCR analysis 
detects four VEGF isoforms in the retina at P5. The predominant form is VEGF 164 that binds to heparan sulfate proteoglycan. (b) VEGF protein 
is located in the vicinity of astrocytes in wild-type retinas (a). (c) VEGF 120 protein distributes further away from the astrocytes and can be 
found around ganglion cells (arrows). (d–l) Flattening of the VEGF gradient leads to filopodia shortening, misorientation (see also Fig. 8) and 
reduced migration (see also Fig. 9, j and k). (d and h) Control injection overview and tip cell filopodia detail. (e and i) VEGF120/120 retinas 
display reduced filopodia length and sprouting but increased vessel diameter. Filopodia also extend in aberrant directions (see also Fig. 9). T
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Although ectopic VEGFR2 agonists inhibited peripheral
spreading, they increased proliferation widely in the retinal
vascular plexus. This was observed in 
 
 
 
A-crystallin–VEGF
transgenics (Fig. 7 f) and after injection of VEGF-A (Fig. 7 g;
unpublished data) or VEGF-E (Fig. 9 d), where the number
of endothelial cells per vessel length, the size of the vessels,
and the plexus density were increased. Together, these obser-
vations demonstrate that in the developing retina tip cell mi-
gration and stalk cell proliferation are independently con-
trolled phenomena that depend on VEGF-A stimulation of
VEGFR2. However, whereas tip cell migration depends on
the extracellular VEGF-A distribution pattern (this study),
stalk cell proliferation appears to depend on the actual
VEGF-A concentration (this study; unpublished data).
 
Discussion
 
We have identified a mechanism by which retinal angiogen-
esis is guided. In response to VEGF-A, specialized endothe-
lial cells situated at the tips of retinal vascular sprouts ex-
tend long filopodia. Extracellular VEGF-A gradients guide
these filopodia, leading to directed migration of tip cells.
These effects are mediated via VEGFR2. VEGF-A reaching
cells situated in the vascular stalks also stimulates their pro-
liferation through the same receptor. The activation of
VEGFR2 is therefore interpreted differently by tip and stalk
cells. The reason for this is currently unclear, and insight
would require additional information about the molecular
differences between the two cell types. Nevertheless, our
study highlights the crucial importance of a balance be-
tween the tip and stalk cell responses to VEGF-A. The co-
ordination between the two responses demands for a metic-
ulous control of extracellular VEGF-A distribution. This
control utilizes cell type (astrocyte), environmental (oxy-
gen), and transcriptional (splicing) dependent mechanisms.
An accurate balance between migration of the tip cell and
proliferation of the stalk cells is only achieved when the cor-
rect relationship between VEGF-A gradient and concentra-
tion occurs as a consequence of these combined control
mechanisms. This provides an elegant illustration of how a
single growth factor may exert intricate control of a com-
plex morphogenetic process. Together with our recent dem-
onstration that heparin-binding VEGF isoforms are re-
quired to shape extracellular VEGF gradients and primary
vascular patterns (Ruhrberg et al., 2002), the present data
provides initial evidence for the development of a mecha-
 
(f and j) VEGF120 transgenes expressing VEGF120 from the lens-specific crystallin promoter. Note massive enlargement of vessel diameter and 
chaotic sprouting and fusion but little sprouting toward the periphery. Filopodia length is also reduced (not quantified). (g and k) Intraocular 
injection of VEGF leads to a similar situation as seen in the VEGF120/120 mice. Reduced sprouting and filopodia length but ongoing proliferation 
(data not depicted) leads to enlarged vessel diameter. Note that in all situations the flattening of VEGF gradients leads to inhibition of filopodia 
extension and migration. Additional misorientation is documented in Fig. 9. (l) Quantification of filopodia length in the control situation, two 
situations of flattened VEGF gradient, however with difference in overall concentration, and one situation with acute VEGF sequestering. 
Each dot represents one filopodium. Data are collected from at least five different retinas for each group.
Figure 8. Disturbance of VEGF gradients 
leads to misguidance of tip cell filopodia. 
Representative illustrations of the tip cell 
in wild-type (a), VEGF120/120 (b), and 
VEGF120tg (c) retinas. Left hand panels 
(a1–c1) show confocal images focused 
around the ILM, middle panels (a2–c2) 
show extended depth of focus ranging 
from the ILM to the fiber layer, and right 
hand panels (a3–c3) show schematic 
z sections. Black bars on the right indicate 
the level and depth of focus in panels 
a1–c1 and a2–c2. (a) Wild-type vessels 
extend filopodia strictly in the plane of 
the astrocytes, thus giving only a faint 
shadow in the level of the ILM (a1, arrow). 
Extended depth of focus reveals smooth 
surface of the stalk cells (a2, arrowheads). 
Orientation and steepness of wild-type 
VEGF gradient is indicated by a white 
arrowhead in a3. (b) VEGF120/120 
tip cells show a characteristic loss of 
polarization leading to ectopic filopodia 
(blow up in inset) that leave the astrocytic 
plane (b1, arrows) and protrude also from 
the stalk cells (b2, arrowheads). This is 
likely to be caused by a flattened VEGF 
gradient (b3, arrowhead). (c) VEGF120tg 
tip cells display the most drastic loss of polarization once they leave the retinal tissue proper (c1). Note the sprout is extending in the plane 
of the ILM. Filopodia contacting the ILM possess characteristic swellings at the ends (inset). Sprouts within the retina also display loss of 
polarization characterized by ectopic filopodia (c1 and c2, arrowheads). Vertical arrowhead in c3 indicates ectopic VEGF 120 expression 
from the lens. Bar, 20  m.T
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nistic understanding of sprouting angiogenesis. This con-
cept may also extend to pathological angiogenesis in which
the formation of chaotic and dysfunctional networks (for
example, in growing tumors and VEGF gene/protein ther-
apy) results from uncontrolled VEGF expression (Carme-
liet, 2000; Carmeliet and Jain, 2000).
 
The tip cell filopodia
 
Filopodia fulfill at least three different functions in a variety
of cell types: intercellular communication, cell migration,
and cell adhesion (Wood and Martin, 2002). Specialized
filopodia may solely be devoted to cell–cell communication,
such as in the 
 
Drosophila
 
 wing imaginal disc where long,
Figure 9. Receptor specificity. (a) Binding of VEGF-E to VEGFR–IgG fusion proteins. VEGFR–IgG fusion proteins were incubated with purified 
histidine-tagged growth factors and precipitated with protein A sepharose. After reducing SDS-PAGE and Western blotting, receptor-bound 
growth factors were detected with pentahistidine antibodies. Both forms of VEGF-E (NZ2 and NZ7) show significant interaction only with 
VEGFR-2, whereas VEGF-A interacts additionally with VEGFR-1 and VEGF-C additionally with VEGFR-3. (b–i) Intraocular injection of VEGFR–
specific ligands at 1  g/ l concentrations. Retinas were fixed after 24 h. (b) Human serum albumin injection has no effect on patterning or 
filopodia (f). (c) VEGFR1-specific ligand leads to macrophage recruitment (round cells) but has no effect on patterning or tip cell filopodia (g). 
(d) VEGFR2-specific ligand mimics VEGF-A injection and VEGF120/120 retinas (compare with Fig. 7, e and g). Note the lack of sprouting but 
increased vessel diameter and density. Only few very short filopodia are present (h, arrow). (e) VEGFR-3–specific ligand VEGF-C156S had no 
effect on patterning or tip cell filopodia (i). (j and k) Spreading of the vascular plexus over the retina is a measure of migration. Under all conditions 
of disturbed VEGF gradients, the spreading of the vasculature toward the periphery is significantly reduced. Examples are shown for VEGF-E 
injection. Overview pictures were taken on P6. Spreading distance as measured from the optic disc is indicated by red doubled arrow.T
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thin filopodial extensions (cytonemes) provide sites of con-
tact and signaling between the disc anterior/posterior center
and outlying cells (Ramirez-Weber and Kornberg, 2000).
Neuronal growth cones use filopodia to probe their environ-
ment for guidance cues but also to migrate (Kater and Reh-
der, 1995; Tessier-Lavigne and Goodman, 1996). Filopodia
and lamellipodia are regularly seen at the leading edge of mi-
grating cells in culture, such as fibroblasts and keratinocytes,
from which they reach out and adhere to the substrate, al-
lowing the cell to pull itself forward.
In endothelial cells, filopodia may serve several of these
functions. Our data indicate that in addition to tip cell
filopodia sensing the VEGF gradient generated by retinal as-
trocytes, it is also probable that tip cells use the filopodia to
attach to the astrocytes or astrocyte-derived matrix and to
migrate. It is tempting to speculate that the latter may in-
volve transient fibronectin deposition on astrocytes, which
we have observed together with fibronectin-type integrin re-
ceptors localized at the tips of the endothelial filopodia (un-
published data)
 
The pleiotrophic actions of VEGF-A
 
Genetic ablation experiments of VEGF-A and VEGFR2 in
mice (Shalaby et al., 1995; Carmeliet et al., 1996; Ferrara et
al., 1996) revealed essential functions in the specification,
differentiation, and assembly of angioblasts into primary vas-
cular plexuses. VEGF also induces angiogenic sprouting (for
review see Ferrara, 2000), vascular permeability (Senger et al.,
1983), and recently proposed, the patterning of arteries
(Lawson et al., 2002; Mukouyama et al., 2002; Stalmans et
al., 2002). Thus, VEGF regulates several different processes
critical for blood vessel formation and function; however, it is
not clear how different cellular effects, like proliferation, mi-
gration, and survival, translate into higher order morphoge-
netic phenomena, such as vascular assembly and sprouting.
Our present results confirm that VEGF-A independently
controls endothelial migration at the tip and proliferation in
the stalk of the angiogenic sprout. Remarkably, these pro-
cesses are functionally independent in that they affect dis-
tinct subpopulations of endothelial cells, and separable,
since stalk cell proliferation can proceed in the absence of tip
cell migration (this study), and vice versa (unpublished
data). This is consistent with earlier studies, demonstrating
separate migratory and proliferative activities during the
process of angiogenesis (Ausprunk and Folkman, 1977;
Sholley et al., 1984). As both functions are mediated by
VEGFR2, the signals must be interpreted differently by the
two endothelial subtypes. Moreover, the pattern of extracel-
lular distribution of VEGF-A is interpreted differently; an
uneven distribution in the form of steep soluble gradients or
focal matrix depositions is a prerequisite for directional tip
cell migration and filopodial extension. Proliferation appar-
ently reflects the local concentration of VEGFR2 agonist.
 
Can the retinal angiogenic guidance paradigm
be generalized?
 
Clearly, the tip-stalk paradigm is not restricted to the retina;
tip cells with the described characteristics are found through-
out the developing CNS (Ruhrberg et al., 2002; unpublished
 
data) during angiogenesis in the aortic ring assay (this study)
and in certain tumor models (unpublished data). The abnor-
mal vessel profiles resulting from the manipulations of reti-
nal VEGF gradients and levels are reminiscent of tumor an-
giogenesis and diabetic microangiopathy. This implicates
abnormalities in the spatial regulation of VEGF/VEGFR
signaling with the abnormal vessel phenotypes seen in these
pathologies. We expect that our suggested model for VEGF-
A–driven developmental angiogenesis will provide a helpful
conceptual framework for the design and interpretation of
future studies of pathological angiogenesis.
 
Materials and methods
 
Animals
 
Descriptive analysis and intraocular injections were performed on wild-
type mice of various strains in order to rule out strain-dependent differ-
ences. The numbers of transgenic mice were as follow: VEGF120/120 (8),
120/wt (22); GFAP-PDGFAtg (15), littermate controls (15); PDGF-A 
 
 
 
/
 
 
 
(3), 
 
 
 
/
 
 
 
 (6), 
 
 
 
/
 
 
 
 (2); 
 
 
 
A–crystallin VEGF120tg (12), littermate controls
(14); 
 
 
 
A–crystallin VEGF164tg (10), littermate controls (7); and 
 
 
 
A–crystal-
lin VEGF188tg (10), littermate controls (8).
 
Whole mount immunohistochemistry and in situ hybridization
 
Eyes were fixed in 4% PFA in PBS at 4
 
 
 
C overnight and washed in PBS.
Retinas were dissected, permeabilized in PBS, 1% BSA, and 0.5% Triton
X-100 at 4
 
 
 
C overnight, rinsed in PBS, washed twice in PBlec (PBS, pH 6.8,
1% Triton-X100, 0.1 mM CaCl
 
2
 
, 0.1 mM MgCl
 
2
 
, 0.1 mM MnCl
 
2
 
), and incu-
bated in biotinylated isolectin B4 (
 
Bandeiraea simplicifolia
 
; L-2140; Sigma-
Aldrich) 20 
 
 
 
g/ml in PBlec at 4
 
 
 
C overnight. After five washes in PBS, sam-
ples were incubated with streptavidin conjugates (Alexa 488, 568, or 633;
Molecular Probes) diluted 1:100 in PBS, 0.5% BSA, and 0.25% Triton
X-100 at 4
 
 
 
C for 6 h. TO-PRO 3 (1:1,000; Molecular Probes) served for nu-
clear staining. After washing and a brief postfixation in PFA, the retinas
were either flat mounted using Mowiol/DABCO (Sigma-Aldrich) or pro-
cessed for multiple labeling. The following antibodies were used: GFAP
(1:75; Z 0334; Dako), VEGFR2 (1:50; 555307; BD PharMingen), VEGFR2
(1:50; AF644; R&D Systems), F4/80 (1:100; MCAP497; Serotec), fibronec-
tin (1:200; A 0245; Dako), VE-cadherin (1:1, culture supernatant provided
by Dietmar Vestweber, University of Muenster, Muenster, Germany), and
Ki67 (1:200; NCL-Ki67p; Novo Castra). Alexa-488, 568, or 633 conjugated
secondary antibodies (Molecular Probes). Rhodamine-phalloidin served for
actin staining (1:40; Molecular Probes). VEGFR2 signal was amplified using
the TSA
 
TM
 
 Fluorescein System (NEL701; NEN) according to instructions.
Flat mounted retinas were analyzed by fluorescence microscopy using a
Nikon E1000 microscope equipped with a digital camera (Nikon Coolpix
990) and by confocal laser scanning microscopy using a Leica LCS NT. Im-
ages were processed using Adobe Photoshop
 
®
 
.
For visualization of vascular lumina, FITC-conjugated Dextran (FD-
2000S; Sigma-Aldrich) was warmed to 37
 
 
 
C and perfused through the
heart of deeply anaesthetized mice (Avertin, intraperitoneally 10 
 
 
 
l/g
body weight).
Mouse VEGF-A, PDGF-B, VEGFR1, and VEGFR2 cDNA fragments were
used for whole mount in situ hybridization as described (Fruttiger, 2002).
For double labeling, immunolabeling was performed after a 10-min post-
fixation in 4% PFA.
BrdU labeling was achieved by a 2-h BrdU pulse before fixation (100 
 
 
 
g
Brd U/g body weight, intraperitoneally). For double labeling, isolectin label-
ing was followed by a 30 min 4% PFA fixation, three washes in PBS, a 1-h in-
cubation in 6 M HCl and 0.1% Triton X-100, six washes in PBT, blocking,
and anti-BrdU antibody (1:50, 347580; BD PharMingen) incubation.
 
Rat aortic ring assay
 
Serum-free aortic ring cultures were established according to the method-
ology of Bonanno et al. (2000) with modifications (unpublished data).
Time-lapse microscopy was performed under low light fluorescence illu-
mination using a Nikon Diaphot 200 inverted microscope and a
Hamamatsu C4742–95 Orca1 CCD camera (Hamamatsu Photonic Sys-
tems). Aortic rings were maintained under normal culture conditions
throughout the filming period. For vital immunostaining, cultures were in-
cubated at 37
 
 
 
C for 30 min with a phycoerythrin-conjugated PECAM-1 an-
tibody (clone TLD-1A2; BD PharMingen) diluted 1:100 in growth medium.T
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After rinsing with growth medium a minimum of five times, the cultures
were set up for filming, and images were captured every 10 or 15 min.
Movies were created and analyzed using Kinetic AQM 2000 software (Ki-
netic Imaging).
For immunostaining, cultures were fixed in ice cold methanol for 10
min, rehydrated in a graded series of methanol/PBS. After a 10-min block in
normal goat serum, PECAM-1 (phycoerythrin or biotin conjugate of the
TLD-1A2 clone; 1:100 in PBS) and rabbit–anti–phospho-histone-H3 (1:200;
Upstate Biotechnology) antibodies were added for 1 h at RT. After washing,
labeling was detected using Alexa-488 streptavidin or goat anti–rabbit IgG
(Molecular Probes). After rinsing with PBS, the areas of sprouting growth
were cut out and mounted in SlowFade AntiFade (Molecular Probes). Imag-
ing was performed on a Carl Zeiss MicroImaging Corp. LSM 510 confocal
microscope, and quantification of sprout and lamellipodia lengths was per-
formed using IPLab Spectrum software (Signal Analytics Corporation).
 
Intraocular injections
 
Pups were deeply anaesthetized by isofluran inhalation. Injections were
performed using 10 
 
 
 
l gastight Hamilton syringes equipped with 33 gauge
needles attached to a micromanipulator. Approximately 0.5 
 
 
 
l (1 
 
 
 
g/
 
 
 
l
sterile filtered solution) was injected (variation due to reflux; delivery was
checked by antibody staining). The following substances were used: Flt-1/
Fc chimera (471-F1–100; R&D Systems), neutralizing VEGFR1 antibody
(AF471; R&D Systems), neutralizing VEGFR2 (AF644; R&D Systems), re-
combinant mouse VEGF-A 164 (493-MV/CF; R&D Systems), recombinant
mouse PlGF-2 (465-PL/CF; R&D Systems), VEGF-E NZ2, VEGF-E NZ7, and
VEGF-C156S (see Protein production).
 
Binding to soluble VEGFR–IgG fusion proteins
 
100 ng of purified protein was incubated for 8 h at 4
 
 
 
C under gentle agita-
tion with equimolar amounts of VEGFR–IgG fusion proteins (Achen et al.,
1998) in PBS supplemented with 0.5% BSA and 0.05% Tween-20 and
1 
 
 g/ml heparin. Receptor-bound growth factors were precipitated with
protein A sepharose, subjected to reducing SDS-PAGE, and after blotting
visualized using pentahistidine antibody (QIAGEN) and the ECL detection
system (Amersham Biosciences).
Protein production
Recombinant proteins were produced using the Bac-to-Bac system (Invit-
rogen). Nucleotides 658–996 (VEGF-C; sequence data available from Gen-
Bank/EMBL/DDBJ under accession no. X94216), 235–801 (VEGF; se-
quence data available from GenBank/EMBL/DDBJ under accession no.
M27281), 329–670 (VEGF-ENZ2; sequence data available from GenBank/
EMBL/DDBJ under accession no. S67520), 387–755 (VEGF-ENZ7; sequence
data available from GenBank/EMBL/DDBJ under accession no. S67522),
and 112–1866 (human serum albumin; sequence data available from Gen-
Bank/EMBL/DDBJ under accession no. V00494) were cloned in-frame into
a modified transfer vector (pFASTBAC1; Invitrogen) in between sequences
coding for a melittin signal peptide and a hexahistidine tag. Human serum
albumin was additionally hexahistidine tagged at the NH2 terminus of the
mature protein in order to deploy the same stringent washing conditions in
the purification as for the dimeric VEGFs. The VEGFR-3–specific mutation
in VEGF-C (C156S) has been described previously (Joukov et al., 1998).
Conditioned serum-free medium (Sf900II; Invitrogen) of High Five cells
was harvested 72 h postinfection and dialyzed against 30 mM sodium
phosphate, 0.4 M sodium chloride, pH 6. The pH was adjusted to 8.0, and
Ni
2 NTA Superflow resin (QIAGEN) was added. Samples were agitated
over night at  4 C, and the resin was then collected and applied to chro-
matography columns. The columns were washed with 30 mM sodium
phosphate, 400 mM sodium chloride, 0.6 M glycerol, 20 mM imidazole at
pH 8.0, and bound proteins were eluted with an imidazole step gradient.
The eluate was dialyzed against PBS or 0.1% TFA and sterilized using
Millex-GV filters (Millipore). The proteins were checked on silver-stained
reducing SDS-PAGE gels and quantitated using the BCA protein assay
(Pierce Chemical Co.).
Online supplemental material
Fig. S1, available at http://www.jcb.org/cgi/content/full/jcb.200302047/
DC1, illustrates the time-lapse analysis of tip cell migration and lamellipo-
dia extension after VEGF sequestration in the aortic ring assay model.
Quantitation of migration and lamellipodia length is presented.
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